Payment overview · 2025
General Payments
$146.10
6 reported records · 3 companies
Healthcare provider profile · identity verified
Caroline Mcwilliams, MD
Allopathic & Osteopathic Physicians|Internal Medicine · MAYS LANDING, NJ · NPI 1346405628
Verified facts
What the public records show
CMS Open Payments records show Caroline Mcwilliams, MD received $146.10 in general payments during 2025 across 6 reported records.
Indivior Inc. accounted for 65.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Indivior Inc. | Unresolved — no canonical attribution shown | $96.01 | 65.7% | 4 | 2025 |
| Alkermes, Inc. | Unresolved — no canonical attribution shown | $33.78 | 23.1% | 1 | 2025 |
| Braeburn Inc. | Unresolved — no canonical attribution shown | $16.31 | 11.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $146.10 | 6 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| SUBLOCADE Normalized: sublocade |
Drug | Indivior Inc. | $96.01 | 4 | 2025 |
Source payment records
|
|||||
| VIVITROL Normalized: vivitrol |
Drug | Alkermes, Inc. | $33.78 | 1 | 2025 |
Source payment records
|
|||||
| BRIXADI Normalized: brixadi |
Drug | Braeburn Inc. | $16.31 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Baclofen | Baclofen | 911 | 77 |
| Gabapentin | Gabapentin | 676 | 64 |
| Levetiracetam | Levetiracetam | 356 | 31 |
| Atorvastatin Calcium | Atorvastatin Calcium | 352 | 38 |
| Tizanidine Hcl | Tizanidine Hcl | 338 | 35 |
| Furosemide | Furosemide | 311 | 25 |
| Eliquis | Apixaban | 297 | 30 |
| Duloxetine Hcl | Duloxetine Hcl | 226 | 20 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 220 | 24 |
| Escitalopram Oxalate | Escitalopram Oxalate | 193 | 20 |
| Trazodone Hcl | Trazodone Hcl | 190 | 22 |
| Tamsulosin Hcl | Tamsulosin Hcl | 167 | 18 |
| Potassium Chloride | Potassium Chloride | 161 | 19 |
| Levothyroxine Sodium | Levothyroxine Sodium | 153 | 14 |
| Amlodipine Besylate | Amlodipine Besylate | 148 | 15 |
| Metoprolol Tartrate | Metoprolol Tartrate | 142 | 18 |
| Divalproex Sodium | Divalproex Sodium | 137 | 12 |
| Famotidine | Famotidine | 132 | 17 |
| Warfarin Sodium | Warfarin Sodium | 131 | suppressed |
| Omeprazole | Omeprazole | 130 | 20 |
| Metformin Hcl | Metformin Hcl | 126 | 16 |
| Mirtazapine | Mirtazapine | 124 | 15 |
| Aripiprazole | Aripiprazole | 119 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 118 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 100 | 13 |
| Quetiapine Fumarate | Quetiapine Fumarate | 87 | suppressed |
| Risperidone | Risperidone | 87 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 85 | 29 |
| Lisinopril | Lisinopril | 82 | suppressed |
| Carvedilol | Carvedilol | 79 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 77 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 75 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 74 | 15 |
| Trulicity | Dulaglutide | 71 | suppressed |
| Amantadine | Amantadine Hcl | 70 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 70 | suppressed |
| Carbamazepine | Carbamazepine | 68 | suppressed |
| Xarelto | Rivaroxaban | 64 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 63 | 21 |
| Amitriptyline Hcl | Amitriptyline Hcl | 62 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 62 | suppressed |
| Metoprolol Succinate | Metoprolol Succinate | 61 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 57 | suppressed |
| Konvomep | Omeprazole/Sodium Bicarbonate | 55 | suppressed |
| Lithostat | Acetohydroxamic Acid | 54 | suppressed |
| Pantoprazole Sodium | Pantoprazole Sodium | 54 | suppressed |
| Calcitriol | Calcitriol | 50 | suppressed |
| Meloxicam | Meloxicam | 50 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 49 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 48 | 24 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 45 | 18 |
| Clonidine Hcl | Clonidine Hcl | 43 | suppressed |
| Linzess | Linaclotide | 43 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 43 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 43 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 41 | 20 |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 38 | 31 |
| Humalog | Insulin Lispro | 37 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 37 | suppressed |
| Phenytoin | Phenytoin | 37 | suppressed |
| Ibuprofen | Ibuprofen | 35 | 11 |
| Lactulose | Lactulose | 35 | suppressed |
| Lamotrigine | Lamotrigine | 35 | suppressed |
| Ketoconazole | Ketoconazole | 34 | 16 |
| Methenamine Mandelate | Methenamine Mandelate | 34 | suppressed |
| Novolog | Insulin Aspart | 33 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 32 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 31 | 11 |
| Leflunomide | Leflunomide | 31 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 30 | suppressed |
| Myrbetriq | Mirabegron | 30 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 29 | suppressed |
| Nifedipine Er | Nifedipine | 29 | suppressed |
| Copaxone | Glatiramer Acetate | 28 | suppressed |
| Losartan Potassium | Losartan Potassium | 28 | suppressed |
| Valproic Acid | Valproic Acid | 28 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 28 | suppressed |
| Allopurinol | Allopurinol | 27 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 27 | suppressed |
| Hydrocortisone | Hydrocortisone | 27 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 27 | suppressed |
| Cephalexin | Cephalexin | 26 | 11 |
| Digoxin | Digoxin | 26 | suppressed |
| Latanoprost | Latanoprost | 26 | suppressed |
| Levofloxacin | Levofloxacin | 26 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 25 | suppressed |
| Haloperidol | Haloperidol | 25 | suppressed |
| Movantik | Naloxegol Oxalate | 25 | suppressed |
| Olanzapine | Olanzapine | 25 | suppressed |
| Ozempic | Semaglutide | 25 | suppressed |
| Spironolactone | Spironolactone | 25 | suppressed |
| Chlorthalidone | Chlorthalidone | 24 | suppressed |
| Clonazepam | Clonazepam | 24 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 23 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 23 | suppressed |
| Sodium Chloride | Sodium Chloride 0.45 % | 23 | suppressed |
| Admelog | Insulin Lispro | 22 | suppressed |
| Jantoven | Warfarin Sodium | 21 | suppressed |
| Methylprednisolone | Methylprednisolone | 21 | suppressed |
| Botox | Onabotulinumtoxina | 20 | 12 |
| Carbamazepine Er | Carbamazepine | 20 | suppressed |
| Finasteride | Finasteride | 20 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 20 | suppressed |
| Topiramate | Topiramate | 20 | suppressed |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 19 | suppressed |
| Entresto | Sacubitril/Valsartan | 19 | suppressed |
| Rebif | Interferon Beta-1a/Albumin | 19 | suppressed |
| Simvastatin | Simvastatin | 19 | suppressed |
| Clonidine | Clonidine | 18 | suppressed |
| Dalfampridine Er | Dalfampridine | 18 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 18 | suppressed |
| Fenofibrate | Fenofibrate | 18 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 18 | suppressed |
| Primidone | Primidone | 18 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 18 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 18 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 17 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 17 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 17 | suppressed |
| Naproxen | Naproxen | 17 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 17 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 16 | suppressed |
| Diazepam | Diazepam | 16 | suppressed |
| Emsam | Selegiline | 16 | suppressed |
| Ertapenem | Ertapenem Sodium | 16 | suppressed |
| Ezetimibe | Ezetimibe | 16 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 16 | suppressed |
| Methimazole | Methimazole | 16 | suppressed |
| Methocarbamol | Methocarbamol | 16 | suppressed |
| Prednisone | Prednisone | 16 | suppressed |
| Roflumilast | Roflumilast | 16 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 16 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 15 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 15 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 15 | suppressed |
| Pimecrolimus | Pimecrolimus | 15 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 15 | suppressed |
| Acetylcysteine | Acetylcysteine | 14 | suppressed |
| Admelog Solostar | Insulin Lispro | 14 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 14 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 14 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 14 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 14 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 14 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 14 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 14 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 14 | suppressed |
| Bromocriptine Mesylate | Bromocriptine Mesylate | 13 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 13 | 11 |
| Citalopram Hbr | Citalopram Hydrobromide | 13 | suppressed |
| Cyclosporine | Cyclosporine | 13 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 13 | suppressed |
| Dimethyl Fumarate | Dimethyl Fumarate | 13 | suppressed |
| Glatopa | Glatiramer Acetate | 13 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 13 | suppressed |
| Nystatin | Nystatin | 13 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 13 | suppressed |
| Pradaxa | Dabigatran Etexilate Mesylate | 13 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 13 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 13 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 12 | suppressed |
| Asenapine Maleate | Asenapine Maleate | 12 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 12 | suppressed |
| Jardiance | Empagliflozin | 12 | suppressed |
| Lansoprazole | Lansoprazole | 12 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 12 | suppressed |
| Restasis | Cyclosporine | 12 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 12 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 11 | suppressed |
| Folic Acid | Folic Acid | 11 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 11 | suppressed |
| Motegrity | Prucalopride Succinate | 11 | suppressed |
| Olanzapine Odt | Olanzapine | 11 | suppressed |
| Sotalol | Sotalol Hcl | 11 | suppressed |
| Teriflunomide | Teriflunomide | 11 | suppressed |
| Timolol Maleate | Timolol Maleate | 11 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $146.10 · 6 records | Indivior Inc. | BRIXADI, SUBLOCADE, VIVITROL | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error